(Q34530950)

2 August 2017

1 reference

title

Clinical pharmacology of etoricoxib: a novel selective COX2 inhibitor (English)

1 reference

2 August 2017

1 reference

Paola Patrignani

1

1 reference

2 August 2017

Marta L Capone

series ordinal

2

1 reference

2 August 2017

Stefania Tacconelli

series ordinal

3

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 February 2003

1 reference

Expert Opinion on Pharmacotherapy

2 August 2017

published in

1 reference

2 August 2017

volume

4

1 reference

2 August 2017

issue

2

1 reference

2 August 2017

page(s)

265-284

1 reference

The coxibs, selective inhibitors of cyclooxygenase-2.

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.265

Cyclooxygenase-selective inhibition of prostanoid formation: transducing biochemical selectivity into clinical read-outs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.265

Why there are two cyclooxygenase isozymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.265

Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.265

Molecular identification of cytosolic prostaglandin E2 synthase that is functionally coupled with cyclooxygenase-1 in immediate prostaglandin E2 biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.265

Regulated formation of eicosanoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.265

Distinct roles of prostaglandin H synthases 1 and 2 in T-cell development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.265

Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.265

Cyclooxygenases in reproductive medicine and biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.265

Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.265

Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.265

Flexibility of the NSAID binding site in the structure of human cyclooxygenase-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.265

Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.265

Rofecoxib, a COX-2 inhibitor, does not inhibit human gastric mucosal prostaglandin production

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.265

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.265

Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.265

Renal effects of COX-2-selective inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.265

Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.265

Interpreting the clinical significance of the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.265

Effects of nimesulide on constitutive and inducible prostanoid biosynthesis in human beings

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.265

In vitro metabolism considerations, including activity testing of metabolites, in the discovery and selection of the COX-2 inhibitor etoricoxib (MK-0663).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.265

Regioselective and stereoselective metabolism of ibuprofen by human cytochrome P450 2C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.265

Results of a randomized, dose-ranging trial of etoricoxib in patients with osteoarthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.265

Efficacy and tolerability profile of etoricoxib in patients with osteoarthritis: A randomized, double-blind, placebo and active-comparator controlled 12-week efficacy trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.265

A multinational randomized, controlled, clinical trial of etoricoxib in the treatment of rheumatoid arthritis [ISRCTN25142273].

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.265

American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.265

Role of prostacyclin in the cardiovascular response to thromboxane A2

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.265

Association between naproxen use and protection against acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.265

Non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease: an observational cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.265

Nonsteroidal anti-inflammatory drug use and acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.265

Lower risk of thromboembolic cardiovascular events with naproxen among patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.265

Cyclooxygenase inhibitors and the antiplatelet effects of aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.265

Overexpression of functionally coupled cyclooxygenase-2 and prostaglandin E synthase in symptomatic atherosclerotic plaques as a basis of prostaglandin E(2)-dependent plaque instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.265

Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.265

The structural basis of aspirin activity inferred from the crystal structure of inactivated prostaglandin H2 synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.265

A high level of cyclooxygenase-2 inhibitor selectivity is associated with a reduced interference of platelet cyclooxygenase-1 inactivation by aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.265

Differential Suppression of Thromboxane Biosynthesis by Indobufen and Aspirin in Patients With Unstable Angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.265

21 January 2018

Towards a better aspirin

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.265

21 January 2018

Identifiers

DOI

10.1517/14656566.4.2.265

1 reference

release_dz65t66slrdizkdmnkatqvujmq

2 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/dz65t66slrdizkdmnkatqvujmq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference